Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02846740 · ClinicalTrials.gov registry record · NA
Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.
A NA study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02846740 is a NA study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 30 participants.
The verdict
NCT02846740, a NA study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This pilot study aims to investigate whether a treatment called cranial electric stimulation or CES can decrease risk factors for suicide. The specific CES device we will use is called Alpha-Stim®. CES will be used in addition to usual treatment (medication and group therapy).
Interventions
- DEVICE Alpha-Stim®.
- BEHAVIORAL Montgomery-Åsberg Depression Rating Scale, Hamilton Anxiety Rating Scale, The Pittsburgh Sleep Quality Index and agitated behavior Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2018-01-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02846740
The ClinicalTrials.gov registry entry for NCT02846740 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Alpha-Stim®. is the first listed.
NCT02846740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02846740 about?
NCT02846740 is a clinical study titled "Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.". This pilot study aims to investigate whether a treatment called cranial electric stimulation or CES can decrease risk factors for suicide. The specific CES device we will use is called Alpha-Stim®. CES will be used in addition to usual treatment (medication and group therapy).
What is the current status of trial NCT02846740?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2017-03-01. Estimated completion is 2018-01-22.
What interventions are being tested in trial NCT02846740?
The interventions under investigation include: Alpha-Stim®. (DEVICE), Montgomery-Åsberg Depression Rating Scale, Hamilton Anxiety Rating Scale, The Pittsburgh Sleep Quality Index and agitated behavior Scale (BEHAVIORAL).
Who is sponsoring clinical trial NCT02846740?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.